![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Lee Clippard
clippard@austin.utexas.edu
512-232-0675
University of Texas at Austin
Caption: This image shows a frog tadpole with normal blood vessel development (fluorescing, top) and a frog tadpole with blood vessel development that was disrupted by the common antifungal medication, thiabendazole (bottom). New research published by Cha et. al. reveals that thiabendazole slows tumor growth and shows promise as a chemotherapy for cancer.
Credit: Hye Ji Cha, The University of Texas at Austin
Usage Restrictions: None
Related news release: Common antifungal drug decreases tumor growth and shows promise as cancer therapy
|